Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of electronic health data to identify patients with moderate-to-severe osteoarthritis of the hip and/or knee and inadequate response to pain medications.

BMC medical research methodology·2023
Same author

Editorial: Pain 360: Emerging topics in the pathophysiology, diagnosis, and treatment of chronic pain.

Frontiers in pain research (Lausanne, Switzerland)·2023
Same author

Exploiting Injury-Induced Peripheral Opioid Receptor Changes in Novel Analgesic Development for Chronic Pain.

Frontiers in pain research (Lausanne, Switzerland)·2022
Same author

Dual-Acting Peripherally Restricted Delta/Kappa Opioid (CAV1001) Produces Antinociception in Animal Models of Sub-Acute and Chronic Pain.

Journal of pain research·2020
Same author

Passing the Baton, Once Again.

Pain practice : the official journal of World Institute of Pain·2017
Same author

The Opioid Epidemic: Root Cause Analysis.

Pain practice : the official journal of World Institute of Pain·2016

Related Experiment Video

Updated: May 26, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Tapentadol for pain: a treatment evaluation.

Craig T Hartrick1, Jose Rafael Rodríguez Hernandez

  • 1Oakland University, William Beaumont School of Medicine, 525 O'Dowd Hall, Rochester, MI 48309, USA. chartrick@beaumont.edu

Expert Opinion on Pharmacotherapy
|December 24, 2011
PubMed
Summary

Tapentadol, a novel analgesic, offers dual action as a mu-opioid agonist and norepinephrine reuptake inhibitor. This unique mechanism provides effective pain relief with potentially fewer gastrointestinal side effects than traditional opioids.

More Related Videos

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing
09:16

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Published on: February 16, 2017

Related Experiment Videos

Last Updated: May 26, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing
09:16

Dynamic Quantitative Sensory Testing to Characterize Central Pain Processing

Published on: February 16, 2017

Area of Science:

  • Pharmacology
  • Pain Management
  • Neuroscience

Background:

  • Tapentadol is a novel analgesic with a dual mechanism of action.
  • It acts as both a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor (MOR-NRI).
  • Preclinical studies suggest synergistic effects between its mu-opioid and norepinephrine reuptake inhibition properties.

Purpose of the Study:

  • To review the pharmacological profile and clinical applications of tapentadol.
  • To highlight its unique MOR-NRI activity and its implications for pain management.
  • To discuss its efficacy and safety profile, particularly in comparison to traditional opioid analgesics.

Main Methods:

  • Review of preclinical data on tapentadol's mechanism of action.
  • Analysis of clinical trial data regarding efficacy and adverse events.
  • Comparison of tapentadol's effects with those of pure opioid agonists.

Main Results:

  • Tapentadol exhibits predominant norepinephrine reuptake inhibition with minimal serotonin effects.
  • It is FDA-approved for moderate to severe acute and chronic pain.
  • Demonstrated reduced gastrointestinal adverse effects compared to pure opioid agonists.
  • Synergistic mu-opioid and alpha(2)-adrenergic effects suggest potential utility in neuropathic pain and hyperalgesia.

Conclusions:

  • Tapentadol represents a novel approach to analgesia with a dual MOR-NRI mechanism.
  • Its distinct pharmacological profile offers potential advantages in pain management, including improved gastrointestinal tolerability.
  • Further research may explore its specific benefits in conditions like neuropathic pain.